FASLG and cancer: On the contrary, cancer-derived EVs are enriched in immunosuppressive proteins, including death receptor ligands such as PD-L1 [143, 144], FasL [145] and TRAIL [146], by which cancer-derived EVs directly induce apoptosis of anti-tumor T cells.